Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 237

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney

Open access
Hutchison, Colin A., Cockwell, Paul, Stringer, Stephanie, Bradwell, Arthur, Cook, Mark, Gertz, Morie A., Dispenzieri, Angela, Winters, Jeffrey L., Kumar, Shaji, Rajkumar, S. Vincent, Kyle, Robert A., Leung, Nelson·2011·Journal of the American Society of Nephrology

Abstract

Myeloma kidney is the major cause of severe irreversible renal failure in patients with multiple myeloma. This tubulointerstitial injury is a direct consequence of high concentrations of circulating monoclonal free light chains (FLCs) produced by a clonal expansion of plasma cells. Early reduction of serum FLCs associates with renal recovery, but the target threshold of reduction to facilitate renal recovery is unknown. To determine the relationship between the achieved FLC reduction and renal recovery, we identified 39 patients with biopsy-proven myeloma kidney, the majority of whom had severe renal failure at presentation (median estimated GFR 9 ml/min per 1.73 m²). In a multivariable analysis incorporating demographic, hematologic, and renal variables, only the achieved FLC reduction significantly predicted renal recovery (P = 0.003). The relationship between renal recovery and FLC reduction was linear with no absolute threshold for FLC reduction. A 60% reduction in FLCs by day 21 associated with recovery of renal function for 80% of the population. Patient survival strongly associated with renal recovery: the median survival was 42.7 months (range 0 to 80) among those who recovered function compared with 7.8 months (range 0 to 54) among those who did not (P < 0.02). Cox-regression analysis demonstrated that the first presentation of myeloma, the kappa isotype of FLC, and renal recovery were independent predictors of survival. In conclusion, recovery of renal function in myeloma kidney depends on early reduction of serum FLCs, and this recovery associates with a significant survival advantage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2010080857

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 237

Metadata

Authors
Hutchison, C. A., Cockwell, P., Stringer, S., Bradwell, A., Cook, M., Gertz, M. A., Dispenzieri, A., Winters, J. L., Kumar, S., Rajkumar, S. V., Kyle, R. A., & Leung, N.
Venue
Journal of the American Society of Nephrology
Published
2011-06
Volume
22
Issue
6
Pages
1129-1136
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2146429012
Cited by
237
References
1
FWCI
9.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney. https://app.cochat.ai/papers/10.1681/asn.2010080857
The paper
Hutchison, C. A., Cockwell, P., Stringer, S., Bradwell, A., Cook, M., Gertz, M. A., Dispenzieri, A., Winters, J. L., Kumar, S., Rajkumar, S. V., Kyle, R. A., & Leung, N. (2011). Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2010080857

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.